Increased antibody titres to measles virus have often been observed in the sera of patients with chronic active hepatitis who are negative for hepatitis B surface antigen (HBs Ag).'-7 Similarly, a higher incidence of autoantibodies, especially smooth muscle antibodies and antinuclear antibodies, has also been detected in the sera of these patients.8-'0 Measles virus, a member of the genus moribillivirus of the family Paramyxoviridae, both haemagglutinates and haemolyses rhesus monkey erthrocytes but lacks neuraminidase." Biological and biochemical analyses of measles virus have shown that the two antigens located on the surface of the virus envelope are haemagglutinin and haemolysin, while the major antigen, nucleocapsid, is held internally within the virion. In addition, both haemagglutinin and haemolysin are expressed on the membrane of cells infected with measles virus, and nucleocapsid is located intracellularly.'2-5 Antibodies against haemagglutinin and haemolysin can be identified separately by the functional tests haemagglutination inhibition and haemolysin inhibition. In contrast, the complement fixation test measures the bulk of the antibody to nucleocapsid, apart from a Accepted for publication 31 July 1985 small proportion of antibody that may be against haemagglutinin.'2 1617 Furthermore, we have shown that measles virus haemolysin is sensitive to acetone and that measles virus haemagglutinin is resistant to acetone, and these differences in the sensitivity of the two antigens can be used to measure antibodies to haemolysin and haemagglutinin antigens in the fluorescence antibody test.'5 18 19 Moreover, in the sera of normal healthy subjects the titres of haemolysin antibodies are always higher than those of haemagglutinin antibodies.'6 18 Therefore, fluorescence antibody titres obtained by staining the membrane of unfixed cells infected with measles virus represent mostly antibodies to haemolysin and the titres obtained by staining the membrane of acetone fixed cells infected with measles virus represent haemagglutinin antibodies. Similarly, the staining of intracellular inclusions in acetone fixed cells represents antibodies to nucleocapsid.'5 18 19 Although both complement fixation and haemagglutination inhibition tests have been used to estimate antibodies specific for measles virus in the sera of patients with chronic active hepatitis, haemolysin inhibition antibodies have not been measured. These antibodies are neutralising'6-'8 and are therefore important in protection against measles infection20; they are also found to be in excess of Shirodaria, McMillan, Callender, Haire, Fleming, Merrett, Fulton haemagglutination inhibition antibodies in healthy immune subjects after primary childhood measles.'6 18 In this study we therefore investigated levels of haemolysin and haemagglutinin antibodies specific for measles virus in the sera of a group of patients with chronic active hepatitis using fluorescence antibody and functional tests. We also examined titres of autoantibodies to determine whether there was a correlation between autoantibodies and the viral antibodies.
Material and methods

PATIENTS AND CONTROLS
Serum samples were obtained from 16 patients with chronic active hepatitis negative for HBs Ag. The patients comprised 13 women and three men (mean age 47-7 years; range 27-74 years). The diagnosis was based on the clinical criteria specified by the Fogerty International Centre, 1976,2' and on histological criteria described by an international group22 for liver biopsy. At the time of the study seven patients had increased serum aspartate aminotransferase and serum alanine aminotransferase activities (range 60-200 U/l) and nine patients had normal activities (10-45 U/l). All the patients also had increased y-globulin values. In five cases a second serum sample was obtained after about 11-22 months. Sera were collected over three years and stored at -20°C until tested. All patients were receiving either prednisolone or adrenocorticotrophic hormone, and seven patients were receiving azathioprine in addition, Control sera were obtained from 16 healthy blood donors (mean age 47 5 years; range 26-74 years). The sera were matched for sex and age within two years.
CELLS AND VIRUS
HEp-2 cell line was obtained from Gibco-Biocult Ltd, and cells were propagated in Eagle's minimal essential medium supplemented with 10% fetal bovine serum and 10% tryptose phosphate broth. Immunofluorescence Semiconfluent monolayers of HEp-2 cells were grown on 13 mm round coverslips in 5 cm petri dishes (2 x 105 cells per dish) in Eagle's growth medium at 37°C for 18 hours in 5% carbon dioxide. The cells were washed once with Eagle's medium without serum and infected at a multiplicity of 0*01 plaque forming units/cell. After adsorption at 37°C for one hour 4 ml of maintenance medium was added and the dishes were incubated for 48 hours at 37°C to give about 30% infected cells. The coverslips were either used unfixed or were fixed in acetone for eight minutes at room temperature after three washes in phosphate buffered saline and one rinse in fresh acetone. The fixed coverslips were air dried for one hour before use or were stored at -20°C before use. The percentage of infected cells in each preparation was routinely confirmed using FITC conjugated monkey antimeasles serum in the direct immunofluorescence test as described previously. 24 The advantage of using this method was that the staining of infected cells could easily be differentiated from that of uninfected cells in the same preparation.
To detect antibodies to measles virus haemolysin serial two fold dilutions of sera in phosphate buffered saline were applied to unfixed coverslip preparations of infected cells that had been rinsed rapidly three times in phosphate buffered saline for 45 minutes at 37°C. After three more quick rinses in phosphate buffered saline FITC conjugated sheep antihuman IgG was applied for 45 minutes at 37°C. After thorough rinsing in phosphate buffered saline the coverslips were mounted in glycerol saline and examined under a fluorescence microscope. The procedure used to detect antibodies to haemagglutinin (including nucleocapsid) was similar to that described for the unfixed preparation, except that instead of quick rinses in phosphate buffered saline the coverslips were washed for 15 minutes in phosphate buffered saline. The fluorescence antibody titre was the highest dilution of the serum that gave specific staining of the membrane of the infected cells for haemolysin antibody and staining of the membrane of the infected acetone fixed cells for haemagglutinin antibody and staining of viral inclusions for nucleocapsid antibody.
Haemagglutination inhibition Serial two fold dilutions of serum were prepared in Dulbecco's phosphate buffered saline (pH 7.4) in 0-025 ml volumes in microtitre plates and mixed with a preparation of haemagglutinin containing four haemagglutinating doses. After incubation at 37°C for one hour an equal volume of washed 1 % suspension of rhesus monkey erythrocytes was added. The erythrocytes were allowed to settle at 37°C for one hour. The highest dilution of serum giving 50% inhibition of agglutination was taken as the titre of the antibody. Haemolysin inhibition Serial two fold dilutions of serum were prepared in Dulbecco's phosphate buffered saline (pH 7.4) in 0-25 ml volumes in three x half inch plastic tubes and mixed with a preparation of haemolysin containing eight haemolysing doses. Table 3 shows the comparison of the virus specific antibodies and autoantibodies in the duplicate sera obtained from five patients after 11-24 months. The results indicated that both the virus specific antibodies and the autoantibodies fluctuated, but as the number of patients was small statistical analysis was not carried out.
CORRELATION BETWEEN VIRUS SPECIFIC ANTIBODIES AND AUTOANTIBODIES
In patients with chronic active hepatitis a highly significant correlation was observed between virus specific haemolysin antibody (unfixed) and smooth muscle antibody of IgG class (r5 = 0-78, p = 0 001; Fig. 2) , whereas the correlation with smooth muscle antibody of IgM class was less significant (rs = 0 54, p = 0.03). A significant correlation was not found between virus specific haemolysin antibody and 25 The absorption of the sera with smooth ithout antinuclear anti-muscle tissue prepared from human myometrium icant correlations were did not affect the titres of the virus specific haemolyecific haemolysin anti-sin or haemagglutinin antibodies but it either aminotransferase and reduced or completely removed the smooth muscle ues (rs = 0-18, p = 0 5; antibody of IgG class. These results are not surpristotal immunoglobulin ing because the smooth muscle used for absorption was a crude preparation that contained all the contractile proteins.26 Therefore, if there were restricted but common antigenic determinants shared by n patients with chronic measles virus and actin of smooth muscle tissue this muscle tissue prepared absorption would not be effective. either removed comIt has been reported recently that monoclonal of smooth muscle anti-antibodies against the protein of intermediate and antimitochondrial filaments of human cells cross react with phospho-1 IgM classes, but the protein of both measles virus and herpes simplex IgG antibodies against virus. In contrast, monoclonal antibodies against emagglutinin including measles virus phosphoprotein did not react with the were not affected.
phosphoprotein of herpes simplex virus and vice versa, indicating recognition by monoclonal antibodies of different antigenic determinants on intermediate filaments.27 Further studies with monothe envelope antigen clonal antibodies to different antigenic determinants rnal antigen nucleocap-of actin will help to elucidate the correlation en shown previously in observed between smooth muscle antibody of IgG hronic active hepatitis, class and haemolysin antibodies specific for measles ibition and complement virus in patients with chronic active hepatitis. we have shown raised
The incidence of antinuclear antibodies of IgG to haemagglutinin but class was-higher in the patients with chronic active tntigen haemolysin. The hepatitis compared with the control group, but there a antigen were found to was no significant correlation between virus specific haemagglutinin;by both haemolysin-an-tibody and antinuclear antibodies of IgG class, contrary to the observations reported by other workers.46 This difference may have been due to the fact that in other studies the complement fixation test was used to measure antibodies specific for measles virus, whereas in our investigation we examined the correlation between envelope haemolysin antigen and antinuclear antibodies of IgG class. It is also important to emphasise that the use of a single method-namely, immunofluorescence-for assay of both measles virus specific antibodies and autoantibodies and their subsequent correlation has an added advantage. Antimitochondrial antibodies, which are considered to be a valuable autoantibody marker in patients with primary biliary cirrhosis but not in those with chronic active hepatitis,8-10 were detected in only a few patients.
The implications of raised levels of antibodies against measles virus envelope antigens and of autoantibodies in patients with chronic active hepatitis are unclear. A role for measles virus in the pathogenesis of chronic active hepatitis has been postulated,3 S-I but so far there is no convincing evidence for the persistence of measles virus antigens or measles virus genome in patients with chronic active hepatitis, nor is there evidence of reinfection in these patients. Similar increased titres of haemolysin inhibition and haemagglutination inhibition antibodies specific for measles virus have also been found in other diseases of unknown aetiology such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus'8 28 29 and probably reflect defects in immunoregulatory mechanisms. For instance, lack of suppressor T lymphocyte function has been reported in all these diseases302 and also in chronic active hepatitis. 33 In view of the fluctuations in titres of both measles virus antibodies and autoantibodies in duplicate sera, further comparative studies on sequential samples from patients with chronic active hepatitis of virus specific antibodies and the factors that help regulate the immune system would be of value.
